RIPE-KG · Version 1.1.0 · Resource
ripekg:retraction-notice/52503
https://w3id.org/ripe/ripe-kg/retraction-notice/52503
| Subject | Predicate | Object |
|---|---|---|
ripekg:evaluation/RIPEA61C486302F135B42 |
prov:used |
ripekg:retraction-notice/52503The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer |
ripekg:retraction-notice/52503The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer |
prism:doi |
10.3389/fonc.2024.1383383 |
ripekg:retraction-notice/52503The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer |
prism:publicationDate |
2024-02-21 |
ripekg:retraction-notice/52503The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer |
prism:publicationName |
Frontiers in Oncology |
ripekg:retraction-notice/52503The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer |
dcterms:publisher |
ripekg:publisher/RIPEP6D94DBCE26C24120Frontiers |
ripekg:retraction-notice/52503The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer |
dcterms:title |
The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer |
ripekg:retraction-notice/52503The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer |
http://purl.org/spar/cito/retracts |
ripekg:work/10.3389%2Ffonc.2023.1132186 |
ripekg:retraction-notice/52503The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer |
rdf:type |
http://purl.org/spar/fabio/RetractionNotice |
ripekg:retraction-notice/52503The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer |
rdf:type |
rdfs:Resource |
ripekg:retraction-notice/52503The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer |
rdf:type |
owl:Thing |
ripekg:retraction-notice/52503The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:retraction-notice/52503The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer |
rdf:type |
ripe:RetractionNoticeRetraction notice |
ripekg:retraction-notice/52503The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer |
rdf:type |
tido:Evidence |
ripekg:retraction-notice/52503The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer |
rdf:type |
tido:PieceOfInformation |
ripekg:retraction-notice/52503The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer |
owl:sameAs |
https://semopenalex.org/work/W4391997558 |
ripekg:retraction-notice/52503The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer |
prov:wasAttributedTo |
ripekg:source/retraction-watchRetraction Watch |
ripekg:retraction-notice/52503The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer |
prov:wasAttributedTo |
ripekg:source/retraction-watchRetraction Watch Database |
ripekg:retraction-notice/52503The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA61C486302F135B42 |
ripekg:retraction-notice/52503The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA61C486302F135B42 |
ripekg:retraction-notice/52503The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer |
ripe:concerns |
ripekg:author/RIPEAU17CB02671DDF8806Ying Zhou |
ripekg:retraction-notice/52503The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer |
ripe:concerns |
ripekg:work/10.3389%2Ffonc.2023.1132186 |
ripekg:retraction-notice/52503The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer |
ripe:rationale |
Concerns/Issues about Third Party Involvement;Fake Peer Review;Investigation by Journal/Publisher;Unreliable Results and/or Conclusions |
ripekg:retraction-notice/52503The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer |
ripe:retractionWatchRecordId |
52503 |
ripekg:retraction-notice/52503The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA61C486302F135B42-human-1-3 |
ripekg:retraction-notice/52503The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA61C486302F135B42-inspectai-1-3 |